Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis - Role of haemodialysis treatment

Nephrology Dialysis Transplantation

Volumn 14, Issue 10, 1999, Pages 2484-2486

  Chodock, Rochelle ^a   Mylonakis, Eleftherios ^a   Shemin, Douglas ^a,b   Runarsdottir, Valgerdur ^a   Yodice, Paul ^a   Renzi, Richard ^a   Tashima, Karen ^a   Towe, Christopher ^a   Rich, Josiah D ^a,c  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

AIDS; Haemodialysis; HIV; Lactic acidosis; Nucleoside analogue

Indexed keywords

DIDANOSINE; LACTIC ACID; LAMIVUDINE; NELFINAVIR; NUCLEOSIDE ANALOG; STAVUDINE; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; FEMALE; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; NAUSEA; PRIORITY JOURNAL; SURVIVAL; TACHYPNEA; VIRUS LOAD; VOMITING;

ACIDOSIS, LACTIC; ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; NUCLEOSIDES; RENAL DIALYSIS;

EID: 0032866065     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.10.2484     Document Type: Article

References (17)

1. Carpenter CC, Fischl MA, Hammer SM et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. J Am Med Assoc 1998; 280: 78-86
2. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med 1997; 25: 1425-1430
3. Chattha G, Arieff AI, Cummings C, Tierney LM. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118: 37-39
4. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337: 508-510
5. Gopinath R, Hutcheon M, Cheema-Dhadli S, Halperin M. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol 1992; 3: 1212-1219
6. Aggarwal A, al-Talib K, Alabrash M. Type B lactic acidosis in an AIDS patient treated with zidovudine. Md State Med J 1996; 45: 929-931
7. Hood VL, Tannen RL. Protection of acid-base balance by pH regulation of acid production. N Engl J Med 1998; 339: 819-826
8. Honkoop P, Scholte HR, de Man RA, Schalm SW. Mitochondrial injury, lessons from the fialuridine trial. Drug Safety 1997; 17: 1-7
9. Parker WB, Cheng YC. Mitochondrial toxicity of antiviral nucleoside analogs. J NIH Res 1994; 8: 57-61
10. Kleiner DE, Gaffey MJ, Sallie R et al. Histopathologic changes associated with fialuridine hepatotoxicity. Mod Pathol 1997; 10: 192-199
11. Fortgang IS, Belitsos PC, Chaisson RE, Moore RD. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol 1995; 90: 1433-1436
12. Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7: 379-385
13. Olano JP, Borucki MJ, Wen JW, Haque AK. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 1995; 21: 973-976
14. Gennari FJ. Acid-base homeostasis in end stage renal disease. Semin Dial 1996; 9: 404-411
15. Hakim RM, Pontzer M, Tilton D, Lazarus JM, Gottlieb MN. Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients. Kidney Int 1985; 28: 535-540
16. Luzzati R. Del Bravo P, Di Perri G, Luzzani A, Concia E. Riboflavine and severe lactic acidosis. Lancet 1999; 353: 901-902
17. Acosta BS, Grimsley EW. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient. South Med J 1999; (4)92: 421-423